StockData

Drugs Made In America Acquisition Corp. (DMAA) stock

DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.90+0.00 (0.00%)

Close on Nov 16, 2026Market cap $264.62MP/E –Yield –

Drugs Made In America Acquisition enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Drugs Made In America Acquisition's enterprise value was $116.80M on Nov 11, 2026, against $108.64M a year earlier.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$116.80M+7.0%
2025Dec 31, 2025$109.11M–

More Drugs Made In America Acquisition figures

See a number that looks wrong?